The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
The role of fluorine in medicinal chemistry: Review Article
Open accessAbstract
The small and highly electronegative fluorine atom can play a remarkable role in medicinal chemistry. Selective installation of fluorine into a therapeutic or diagnostic small molecule candidate can enhance a number of pharmacokinetic and physicochemical properties such as improved metabolic stability and enhanced membrane permeation. Increased binding affinity of fluorinated drug candidates to target protein has also been documented in a number of cases. A further emerging application of the fluorine atom is the use of 18F as a radiolabel tracer atom in the exquisitely sensitive technique of Positron Emission Tomography (PET) imaging. This short review aims to bring together these various aspects of the use of fluorine in medicinal chemistry applications, citing selected examples from across a variety of therapeutic and diagnostic settings. The increasingly routine incorporation of fluorine atom(s) into drug candidates suggests a bright future for fluorine in drug discovery and development. A major challenge moving forward will be how and where to install fluorine in a rational sense to best optimise molecular properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Penning, T. D., Talley, J. J., Bertenshaw, S. R., Carter, J. S., Collins, P. W., Docter, S., Graneto, M. J., Lee, L. F., Malecha, J. W., Miyashiro, J. M., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960803q · Cited by 1,965
Fluorine in Medicinal Chemistry
Böhm, H., Banner, D., Bendels, S., Kansy, M., Kuhn, B., Müller, K., Obst‐Sander, U., & Stahl, M. (2004) · ChemBioChem · doi:10.1002/cbic.200301023 · Cited by 1,572
Fluorine in medicinal chemistry: A review of anti-cancer agents
Isanbor, C., & O’Hagan, D. (2006) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2006.01.011 · Cited by 1,120
Chambers, R. D. (2004) · Wiley eBooks · doi:10.1002/9781444305371 · Cited by 1,085
Fluorine in medicinal chemistry: Recent therapeutic applications of fluorinated small molecules
Kirk, K. L. (2006) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2006.06.007 · Cited by 900
The fluoroquinolone antibacterials: past, present and future perspectives
Appelbaum, P. C., & Hunter, P. A. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00192-8 · Cited by 629
Metabolism of Fluorine-Containing Drugs
Park, B. K., Kitteringham, N. R., & O'Neill, P. M. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.443 · Cited by 610
Mortimer, C. G., Wells, G., Crochard, J.-P., Stone, E. L., Bradshaw, T. D., Stevens, M. F. G., & Westwell, A. D. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050942k · Cited by 475
Self-citationHow Strong Is the Cα−H···OC Hydrogen Bond?
Vargas, R., Garza, J., Dixon, D. A., & Hay, B. P. (2000) · Journal of the American Chemical Society · doi:10.1021/ja993600a · Cited by 415
Rosenblum, S. B., Huynh, T., Afonso, A., Davis, H. R., Yumibe, N., Clader, J. W., & Burnett, D. A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970701f · Cited by 361
Hutchinson, I., Chua, M.-S., Browne, H. L., Trapani, V., Bradshaw, T. D., Westwell, A. D., & Stevens, M. F. G. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm001104n · Cited by 354
Self-citationApplication of fluoroquinolone pharmacodynamics
Wright, D. H. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.5.669 · Cited by 342
9α-FLUORO DERIVATIVES OF CORTISONE AND HYDROCORTISONE
Fried, J., & Sabo, E. F. (1954) · Journal of the American Chemical Society · doi:10.1021/ja01634a101 · Cited by 323
Radiohalogens for imaging and therapy
Adam, M. J., & Wilbur, D. S. (2005) · Chemical Society Reviews · doi:10.1039/b313872k · Cited by 260
Olsen, J. A., Banner, D. W., Seiler, P., Obst Sander, U., D'Arcy, A., Stihle, M., Müller, K., & Diederich, F. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200351268 · Cited by 204
Selective Fluorination in Drug Design and Development: An Overview of Biochemical Rationales
Kirk, K. L. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606777951073 · Cited by 136
Kim, C., Chang, J. S., Doyon, J. B., et al. (2000) · Journal of the American Chemical Society · doi:10.1021/ja002627n · Cited by 134
Positron emission tomography in clinical neurology
Herholz, K., & HEISS, W. (2004) · Molecular Imaging and Biology · doi:10.1016/j.mibio.2004.05.002 · Cited by 119
A new class of carbonic anhydrase inhibitor.
Maren, T. H., & Conroy, C. W. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74305-1 · Cited by 108
18F-labeled radiopharmaceuticals for PET in oncology, excluding FDG
Varagnolo, L., Stokkel, M. P. M., Mazzi, U., & Pauwels, E. K. J. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(99)00109-2 · Cited by 90
Potential 18F-labeled biomarkers for epidermal growth factor receptor tyrosine kinase
Bonasera, T. A., Ortu, G., Rozen, Y., Krais, R., Freedman, N. M. T., Chisin, R., Gazit, A., Levitzki, A., & Mishani, E. (2001) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(01)00200-1 · Cited by 87
Enzyme inhibition by fluoro compounds.
Abeles, R. H., & Alston, T. A. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44813-7 · Cited by 85
Protein Tyrosine Phosphatase 1B: A Novel Target for Type 2 Diabetes and Obesity
Ramachandran, C., & Kennedy, B. P. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452276 · Cited by 55
Brantley, E. J., Trapani, V., Alley, M. C., Hose, C. D., Bradshaw, T. D., Stevens, M. F. G., Sausville, E. A., & Stinson, S. F. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001057 · Cited by 52
Fluorinated Molecules as Drugs and Imaging Agents in the CNS
Sun, S., & Adejare, A. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606777951046 · Cited by 48
Rahimtula, A. D., O'Brien, P. J., Seifried, H. E., et al. (1978) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1978.tb20905.x · Cited by 47
Positron emission tomography: the conceptual idea using a multidisciplinary approach
Paans, A. M. J. (2002) · Methods · doi:10.1016/s1046-2023(02)00075-0 · Cited by 47
Potent non-6-fluoro-substituted quinolone antibacterials: synthesis and biological activity
Ledoussal, B., BOUZARD, D., & Coroneos, E. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00079a028 · Cited by 44
Muehlbacher, M., & Poulter, C. D. (1985) · Journal of the American Chemical Society · doi:10.1021/ja00312a107 · Cited by 38
Clinical imaging of cancer metastasis
Glasspool, R. M., & Evans, T. R. J. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00154-4 · Cited by 35
Discovery and structure–activity relationships of novel sulfonamides as potent PTP1B inhibitors
Holmes, C. P., Li, X., Pan, Y., Xu, C., Bhandari, A., Moody, C. M., Miguel, J. A., Ferla, S. W., Francisco, M. N. D., Frederick, B. T., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.06.061 · Cited by 35
PET radiopharmaceuticals for metabolic imaging in oncology
Wiebe, L. I. (2004) · International Congress Series · doi:10.1016/j.ics.2003.12.102 · Cited by 20
Muehlbacher, M., & Poulter, C. D. (1986) · ChemInform · doi:10.1002/chin.198616260 · Cited by 5
Cited by
Applications of Fluorine in Medicinal Chemistry
Gillis, E. P., Eastman, K. J., Hill, M. D., Donnelly, D. J., & Meanwell, N. A. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00258 · Cited by 3,618
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
Meanwell, N. A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1013693 · Cited by 2,854
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
Meanwell, N. A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01788 · Cited by 2,655
Carbon Trifluoromethylation Reactions of Hydrocarbon Derivatives and Heteroarenes
Alonso, C., Martínez de Marigorta, E., Rubiales, G., & Palacios, F. (2015) · Chemical Reviews · doi:10.1021/cr500368h · Cited by 1,073
Chemical Aspects of Human and Environmental Overload with Fluorine
Han, J., Kiss, L., Mei, H., Remete, A. M., Ponikvar-Svet, M., Sedgwick, D. M., Roman, R., Fustero, S., Moriwaki, H., & Soloshonok, V. A. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01263 · Cited by 537
Metadata
- Authors
- Shah, P., & Westwell, A. D.
- Venue
- Journal of Enzyme Inhibition and Medicinal Chemistry
- Publisher
- Informa UK Limited
- Published
- 2007-01
- Volume
- 22
- Issue
- 5
- Pages
- 527-540
- ISSN
- 1475-6366 (ISSN-L)
- 1475-6374
- OpenAlex
- W2140310496
- Cited by
- 799
- References
- 33
- FWCI
- 7.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.